InvestorsHub Logo
Followers 11
Posts 1461
Boards Moderated 0
Alias Born 10/18/2018

Re: RobotDroid post# 35916

Wednesday, 02/24/2021 4:00:35 PM

Wednesday, February 24, 2021 4:00:35 PM

Post# of 43855
Researchers at Northern Arizona University have come up with a one-two punch they claim knocks out COVID-19. It combines an ovarian cancer medication with remdesivir to stop the virus from entering cells and inhibit its replication.


Researchers at NAU’s COVID-19 Testing Service Center (CTSC) found that the drug stenoparib, which is in clinical trials to treat ovarian cancer, blocked the replication of SARS-CoV-2, the virus that causes COVID-19 in lab tests. They paired stenoparib with remdesivir, which is already approved by the Food and Drug Administration to treat COVID-19, according to an NBC news outlet in Phoenix.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News